Literature DB >> 11226761

Dyspnea in cancer patients: prevalence and associated factors.

D J Dudgeon1, L Kristjanson, J A Sloan, M Lertzman, K Clement.   

Abstract

The objectives of this study were to determine the prevalence of dyspnea in the general cancer population, the intensity of the symptom as perceived by the patient, and the patient characteristics associated with the presence of dyspnea. Nine hundred and twenty-three cancer outpatients completed visual analogue scales (VAS) and verbal rating scales (VRS-D) to assess the intensity of their dyspnea. Baseline data included variables that were known covariates of dyspnea. Forty-six percent of the patients had some shortness of breath. Only 4% had a diagnosis of lung cancer and 5.4% lung metastases. Risk factors found to be significantly related to the presence of dyspnea were history of smoking; asthma or chronic obstructive pulmonary disease (COPD); lung irradiation; or a history of exposure to asbestos, coal dust, cotton dust or grain dust (P values from 0.001 to 0.038). The prevalence of dyspnea was strongly related to the number of risk factors a patient had (P < 0.0001). The VAS and VRS-D were significantly correlated, establishing concurrent validity for the VRS-D.

Entities:  

Mesh:

Year:  2001        PMID: 11226761     DOI: 10.1016/s0885-3924(00)00258-x

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  32 in total

1.  Dyspnea and panic among patients with newly diagnosed non-small cell lung cancer.

Authors:  Jennifer A Shin; Jesse D Kosiba; Lara Traeger; Joseph A Greer; Jennifer S Temel; William F Pirl
Journal:  J Pain Symptom Manage       Date:  2014-04-21       Impact factor: 3.612

2.  A brief symptom index for advanced lung cancer.

Authors:  Susan Yount; Jennifer Beaumont; Sarah Rosenbloom; David Cella; Jyoti Patel; Thomas Hensing; Paul B Jacobsen; Karen Syrjala; Amy P Abernethy
Journal:  Clin Lung Cancer       Date:  2011-05-23       Impact factor: 4.785

3.  Randomized Pilot Trial of a Telephone Symptom Management Intervention for Symptomatic Lung Cancer Patients and Their Family Caregivers.

Authors:  Catherine E Mosher; Joseph G Winger; Nasser Hanna; Shadia I Jalal; Lawrence H Einhorn; Thomas J Birdas; DuyKhanh P Ceppa; Kenneth A Kesler; Jordan Schmitt; Deborah A Kashy; Victoria L Champion
Journal:  J Pain Symptom Manage       Date:  2016-07-09       Impact factor: 3.612

4.  Certain bio-psychosocial-spiritual problems associated with dyspnea among advanced cancer patients in Taiwan.

Authors:  Chih-Te Ho; Hua-Shui Hsu; Chia-Ing Li; Chiu-Shong Liu; Chin-Yu Lin; Cheng-Chieh Lin; Wen-Yuan Lin
Journal:  Support Care Cancer       Date:  2011-09-27       Impact factor: 3.603

5.  Dyspnea in palliative care: expanding the role of corticosteroids.

Authors:  Richard J Lin; Ronald D Adelman; Sonal S Mehta
Journal:  J Palliat Med       Date:  2012-03-02       Impact factor: 2.947

6.  Management of dyspnea in palliative care.

Authors:  A M Crombeen; E J Lilly
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

7.  Coping Skills Practice and Symptom Change: A Secondary Analysis of a Pilot Telephone Symptom Management Intervention for Lung Cancer Patients and Their Family Caregivers.

Authors:  Joseph G Winger; Kevin L Rand; Nasser Hanna; Shadia I Jalal; Lawrence H Einhorn; Thomas J Birdas; DuyKhanh P Ceppa; Kenneth A Kesler; Victoria L Champion; Catherine E Mosher
Journal:  J Pain Symptom Manage       Date:  2018-01-31       Impact factor: 3.612

Review 8.  Dyspnea in lung cancer patients: a systematic review.

Authors:  Ganesan Kathiresan; Reynold F Clement; Meera T Sankaranarayanan
Journal:  Lung Cancer (Auckl)       Date:  2010-11-22

9.  Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.

Authors:  Anita R Peoples; Peter W Bushunow; Sheila N Garland; Charles E Heckler; Joseph A Roscoe; Luke L Peppone; Deborah J Dudgeon; Jeffrey J Kirshner; Tarit K Banerjee; Judith O Hopkins; Shaker R Dakhil; Marie A Flannery; Gary R Morrow
Journal:  Support Care Cancer       Date:  2015-09-02       Impact factor: 3.603

10.  Oral morphine and respiratory function amongst hospice inpatients with advanced cancer.

Authors:  T D Walsh; N I Rivera; R Kaiko
Journal:  Support Care Cancer       Date:  2003-10-24       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.